Overview Markets Watchlist

© 2026 IR SuperintelMethodology Contact

Checkpoint Therapeutics Inc

CUSIP: 162828956 | 4 institutional holders

Quarters

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile